Hereditary Angioedema Market Snapshot: Room For Pills And Injections As Prophylaxis Makes Gains

 
• By Ayisha Sharma

While many HAE patients converted from injectable prophylaxis to BioCryst’s oral Orladeyo last year, physicians said a promising injectable candidate from Ionis could benefit from varied patient preference.  

Dozens of colourful balloons are released into the sky at the International Rare Disease Day in Sofia, Bulgaria
Hereditary Angioedema Is a Rare Disease That Causes Extreme Swelling • Source: Alamy

More from Market Snapshot

More from Scrip